Transition from intravenous to subcutaneous biological therapies in inflammatory bowel disease: An online survey of patients.
Daniele NapolitanoCarlo Romano SettanniLaura ParisioNicoletta OrgianaAndrea PosciaElisa SchiavoniLaura TurchiniAlessio Lo CascioFrancesco GerminiElena SblendorioAlessandra MilaniChristopher PatterilLucrezia LaterzaLoris Riccardo LopetusoDaniela PuglieseAlfredo PapaAntonio GasbarriniFranco ScaldaferriPublished in: Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology (2024)
The transition from in-hospital to subcutaneous therapeutic management of biological therapy at home was generally viewed favorably by patients, especially if they have commitments or were residents far from the IBD center.